Arcus Biosciences RCUS Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$369M+5.6% | -$353M-24.7% | -$341M-26.3% | -$298M-19.7% | -$391M-69.3% | ||
| $9M-10.0% | $10M0.0% | $10M0.0% | $10M+11.1% | $10M+11.1% | ||
| $63M-12.5% | $60M-21.1% | $62M-19.5% | $67M-11.8% | $72M-2.7% | ||
| -$488M— | -$482M— | -$462M— | —— | —— | ||
| —— | —— | —— | —— | $3M-88.0% | ||
| —— | —— | —— | —— | —— | ||
| $349M+81.8% | $488M+74.9% | $202M-28.4% | $242M+0.8% | $192M-26.4% | ||
| —— | —— | —— | —— | —— | ||
| -$489M— | -$484M— | -$464M— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Arcus Biosciences's cash flow data come from?
- Every line is extracted from Arcus Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.